-transparent.png){kind=logo}
The calcium antagonist bepridil (bepridil monohydrochloride monohydrate, Org 5730, Cordium) was investigated in comparison with verapamil in a double-blind cross-over design in patients with angina pectoris. Exercise parameters, frequency of anginal attacks, consumption of nitroglycerin and subjective preference were analysed for 36 patients. The exercise capacity, estimated by exercise time and total work load during standard bicycle testing, was significantly more improved with bepridil treatment than with verapamil treatment. No significant differences were observed in frequencies of anginal attack, consumption of nitroglycerin and subjective preference. Side effects were mild and equally divided over both treatment groups.
H K Nielsen, and
L R Krusell, and
S E Husted, and
R J Pluymers
January 1982,
Circulation,
H K Nielsen, and
L R Krusell, and
S E Husted, and
R J Pluymers
March 1985,
The American journal of cardiology,
H K Nielsen, and
L R Krusell, and
S E Husted, and
R J Pluymers
November 1982,
The American journal of cardiology,
H K Nielsen, and
L R Krusell, and
S E Husted, and
R J Pluymers
June 1985,
Zeitschrift fur Kardiologie,
H K Nielsen, and
L R Krusell, and
S E Husted, and
R J Pluymers
January 1997,
European journal of clinical pharmacology,
H K Nielsen, and
L R Krusell, and
S E Husted, and
R J Pluymers
May 1991,
The Medical letter on drugs and therapeutics,
H K Nielsen, and
L R Krusell, and
S E Husted, and
R J Pluymers
November 1982,
The American journal of cardiology,
H K Nielsen, and
L R Krusell, and
S E Husted, and
R J Pluymers
January 1984,
Chest,
H K Nielsen, and
L R Krusell, and
S E Husted, and
R J Pluymers
April 1988,
Cardiologia (Rome, Italy),
H K Nielsen, and
L R Krusell, and
S E Husted, and
R J Pluymers
March 1985,
The American journal of cardiology,
